HOME Top Market Reports Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017

Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017

By: marketsandmarkets.com
Publishing Date: October 2012
Report Code: HIT 1307

Discount on Reports  

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The life science industry is now witnessing the second decade of “Biologic Revolution”. The adoption and up gradation of technology is increasing rapidly. Conventional practices are being replaced by advanced technologies. The perception of pathological laboratories needs to be improved as the consumer expectations and government regulations towards improved patient safety, accurate diagnosis, Electronic Medical Records (EMR) as well as personalized medicines are growing. Pathology plays a significant role in patient care. Digital pathology serves this purpose by providing a facility for digital transformation of pathology and laboratory medicine.

Digital pathology is currently gaining momentum as pathologists are seeking to achieve workflow efficiency and cost cutting in the pathological process. It provides ready access to premium quality slide images, enabling better and fast diagnosis, as well as preservation of these digital slides for future reference. The digital pathology market is driven by the factors such as reduction in laboratory expenses, improvement in operational efficiency, and treatment decisions and patient care. The rising prevalence of cancer, increasing trends in drug development, companion diagnostics, and ease of consultation are the major drivers that are slated to propel this market. However, a few pivotal factors restraining the growth of this market are FDA regulations in some regions, high cost of Digital Pathology Systems (DPS), technological problems, and conservative outlook of pathologists. There are a few well-established firms and several small ones operating in this industry. The major players in the market are Aperio Technologies, Inc. (U.S.), Ventana Medical Systems (U.S.), Leica Microsystems GmbH (Germany), 3DHistech, Ltd (Hungary), and Hamamatsu Photonics (Japan).

The market is broadly segmented into two categories based on its products and application. The product category includes scanners, analytics (visualization software, information management systems and image analysis platforms), storage and communication (sharing services, software), while the application category comprises human pathology and animal pathology. Both these markets are dominated by North America in 2012, followed by Europe, Asia, and Rest of the World (RoW). This market is estimated to be $191.00 million in 2012, and is poised to grow at a CAGR of 12% to reach $336.61 million by 2017.

This market is dominated by the North America, followed by Europe, Asia, and Rest of the World. North America will continue to lead this market for the next five years in spite of stringent FDA regulations and premarketing approvals. This is due to the increasing adoption of digital pathology systems by research labs, pharmaceutical and biotechnology companies, clinical research institutes, contract research organizations, etc. Moreover, the capacity to spend money is also driving the growth in this geography. However, a robust growth rate will be observed in Europe as vendors and manufacturers will be seen turning towards the region for regulatory reliefs. The Asian region’s contribution to this market is also expected to pick up in the coming years, as the technology gets more recognition and becomes more cost effective.

Scope of the Report

This research report categorizes this market into different segments based on its products and application.

Global market, by products

  • Scanners
  • Analytics
  • Storage
  • Communication

Global market, by application

  • Human Pathology
    • Pharmaceutical and Biotechnology companies 
    • Clinical Research
    • Education
  • Animal Pathology
    • Pharmaceutical and Biotechnology companies
    • Academic and Government Research
    • Contract Research Organizations

GEOGRAPHIC ANALYSIS

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Denmark
    • Norway
    • Sweden
    • Rest of Europe
  • Asia
    • China
    • Japan
    • India
    • Rest of Asia
  • Rest of the World (RoW)
    • Latin America
    • Africa
    • Russia
    • Middle East
    • Pacific Countries

TABLE OF CONTENTS 
 
1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 EVOLUTION
  3.3 MARKET SEGMENTATION
      3.3.1 INTRODUCTION
  3.4 MARKET DYNAMICS
      3.4.1 DRIVERS
            3.4.1.1 Rising Prevalence of Cancer
            3.4.1.2 Improvement in Lab Efficiency
            3.4.1.3 Drug Development
            3.4.1.4 Companion Diagnostics
            3.4.1.5 Ease of Consultation
      3.4.2 RESTRAINTS
            3.4.2.1 High Cost of Digital Pathology Systems
            3.4.2.2 Regulatory Concerns
            3.4.2.3 Technological Problems
            3.4.2.4 Conservative Outlook of Pathologists
      3.4.3 OPPORTUNITIES
            3.4.3.1 Affordable Scanners for Private Pathology Practices
            3.4.3.2 Biopharmaceuticals and Drug Toxicology Studies
            3.4.3.3 Personalized Medicine
            3.4.3.4 Workflow Organization in Pathology Labs
  3.5 MARKET SHARE ANALYSIS, BY KEY PLAYERS

4 DIGITAL PATHOLOGY: RATIONALE FOR ADOPTION
  4.1 INTRODUCTION
  4.2 ADVANTAGES OF DIGITAL PATHOLOGY
      4.2.1 GEOGRAPHIC DISTRIBUTION OF PATHOLOGISTS
      4.2.2 CASE TRANSPORT
      4.2.3 CASE REVIEW
      4.2.4 ADDITIONAL STUDIES
      4.2.5 DIAGNOSIS ENTRY
      4.2.6 QUALITY CONTROL
  4.3 WHY A LAB SHOULD ADOPT DIGITAL PATHOLOGY TECHNOLOGY

5 GLOBAL MARKET, BY PRODUCTS
  5.1 INTRODUCTION
  5.2 SCANNERS
  5.3 ANALYTICS
      5.3.1 VISUALIZATION SOFTWARE
      5.3.2 DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEM
      5.3.3 IMAGE ANALYSIS PLATFORMS
  5.4 STORAGE
  5.5 COMMUNICATION/DELIVERY MODES
      5.5.1 WEB-BASED
      5.5.2 CLOUD-BASED

6 GLOBAL MARKET, BY APPLICATION
  6.1 INTRODUCTION
  6.2 HUMAN PATHOLOGY
      6.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      6.2.2 HOSPITALS/REFERENCE LABS/ACADEMIC MEDICAL CENTERS (AMC)
      6.2.3 EDUCATION
  6.3 ANIMAL PATHOLOGY
      6.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      6.3.2 ACADEMIC & GOVERNMENT RESEARCH
      6.3.3 CONTRACT RESEARCH ORGANIZATIONS

7 GEOGRAPHIC ANALYSIS
  7.1 INTRODUCTION
  7.2 NORTH AMERICA
      7.2.1 U.S.
      7.2.2 CANADA
  7.3 EUROPE
      7.3.1 U.K.
      7.3.2 GERMANY
      7.3.3 ITALY
      7.3.4 FRANCE
      7.3.5 SPAIN
      7.3.6 DENMARK
      7.3.7 NORWAY
      7.3.8 SWEDEN
      7.3.9 REST OF EUROPE
  7.4 ASIA
      7.4.1 CHINA
      7.4.2 JAPAN
      7.4.3 INDIA
      7.4.4 REST OF ASIA
  7.5 ROW (REST OF THE WORLD)
      7.5.1 LATIN AMERICA
      7.5.2 AFRICA
      7.5.3 RUSSIA
      7.5.4 MIDDLE EAST
      7.5.5 PACIFIC COUNTRIES

8 COMPETITIVE LANDSCAPE
  8.1 INTRODUCTION
  8.2 MERGERS & ACQUISITIONS
  8.3 AGREEMENTS/PARTNERSHIPS/COLLABORATIONS/ JOINT VENTURES
  8.4 NEW PRODUCT LAUNCH
  8.5 OTHER DEVELOPMENTS

9 COMPANY PROFILES
  9.1 3DHISTECH, LTD
      9.1.1 OVERVIEW
      9.1.2 FINANCIALS
      9.1.3 PRODUCTS & SERVICES
      9.1.4 STRATEGY
      9.1.5 DEVELOPMENTS
  9.2 APERIO TECHNOLOGIES, INC.
      9.2.1 OVERVIEW
      9.2.2 FINANCIALS
      9.2.3 PRODUCTS & SERVICES
      9.2.4 STRATEGY
      9.2.5 DEVELOPMENTS
  9.3 APOLLO PACS, INC.
      9.3.1 OVERVIEW
      9.3.2 FINANCIALS
      9.3.3 PRODUCTS & SERVICES
      9.3.4 STRATEGY
      9.3.5 DEVELOPMENTS
  9.4 AURORA INTERACTIVE, LTD.
      9.4.1 OVERVIEW
      9.4.2 FINANCIALS
      9.4.3 PRODUCTS & SERVICES
      9.4.4 STRATEGY
      9.4.5 DEVELOPMENTS
  9.5 CORISTA, LLC
      9.5.1 OVERVIEW
      9.5.2 FINANCIALS
      9.5.3 PRODUCTS & SERVICES
      9.5.4 STRATEGY
      9.5.5 DEVELOPMENTS
  9.6 DEFINIENS AG
      9.6.1 OVERVIEW
      9.6.2 FINANCIALS
      9.6.3 PRODUCTS & SERVICES
      9.6.4 STRATEGY
      9.6.5 DEVELOPMENTS
  9.7 DIGIPATH, INC.
      9.7.1 OVERVIEW
      9.7.2 FINANCIALS
      9.7.3 PRODUCTS & SERVICES
      9.7.4 STRATEGY
      9.7.5 DEVELOPMENTS
  9.8 HAMAMATSU PHOTONICS K.K.
      9.8.1 OVERVIEW
      9.8.2 FINANCIALS
      9.8.3 PRODUCTS & SERVICES
      9.8.4 STRATEGY
      9.8.5 DEVELOPMENTS
  9.9 HURON TECHNOLOGIES INTERNATIONAL, INC.
      9.9.1 OVERVIEW
      9.9.2 FINANCIALS
      9.9.3 PRODUCTS & SERVICES
      9.9.4 STRATEGY
      9.9.5 DEVELOPMENTS
  9.10 INDICA LABS, INC.
       9.10.1 OVERVIEW
       9.10.2 FINANCIALS
       9.10.3 PRODUCTS & SERVICES
       9.10.4 STRATEGY
       9.10.5 DEVELOPMENTS
  9.11 LEICA MICROSYSTEMS GMBH
       9.11.1 OVERVIEW
       9.11.2 FINANCIALS
       9.11.3 PRODUCTS & SERVICES
       9.11.4 STRATEGY
       9.11.5 DEVELOPMENTS
  9.12 LIGOLAB, LLC
       9.12.1 OVERVIEW
       9.12.2 FINANCIALS
       9.12.3 PRODUCTS & SERVICES
       9.12.4 STRATEGY
       9.12.5 DEVELOPMENTS
  9.13 MIKROSCAN TECHNOLOGIES, INC.
       9.13.1 OVERVIEW
       9.13.2 FINANCIALS
       9.13.3 PRODUCTS & SERVICES
       9.13.4 STRATEGY
       9.13.5 DEVELOPMENTS
  9.14 NIKON INSTRUMENTS, INC.
       9.14.1 OVERVIEW
       9.14.2 FINANCIALS
       9.14.3 PRODUCTS & SERVICES
       9.14.4 STRATEGY
       9.14.5 DEVELOPMENTS
  9.15 OMNYX, LLC
       9.15.1 OVERVIEW
       9.15.2 FINANCIALS
       9.15.3 PRODUCTS & SERVICES
       9.15.4 STRATEGY
       9.15.5 DEVELOPMENTS
  9.16 PATHCENTRAL, INC.
       9.16.1 OVERVIEW
       9.16.2 FINANCIALS
       9.16.3 PRODUCTS & SERVICES
       9.16.4 STRATEGY
       9.16.5 DEVELOPMENTS
  9.17 PATHXL
       9.17.1 OVERVIEW
       9.17.2 FINANCIALS
       9.17.3 PRODUCTS & SERVICES
       9.17.4 STRATEGY
       9.17.5 DEVELOPMENTS
  9.18 PIXCELLDATA, LTD.
       9.18.1 OVERVIEW
       9.18.2 FINANCIALS
       9.18.3 PRODUCTS & SERVICES
       9.18.4 STRATEGY
       9.18.5 DEVELOPMENTS
  9.19 SUNQUEST INFORMATION SYSTEMS
       9.19.1 OVERVIEW
       9.19.2 FINANCIALS
       9.19.3 PRODUCTS & SERVICES
       9.19.4 STRATEGY
       9.19.5 DEVELOPMENTS
  9.20 VENTANA MEDICAL SYSTEMS, INC.
       9.20.1 OVERVIEW
       9.20.2 FINANCIALS
       9.20.3 PRODUCTS & SERVICES
       9.20.4 STRATEGY
       9.20.5 DEVELOPMENTS
  9.21 VISIOPHARM
       9.21.1 OVERVIEW
       9.21.2 FINANCIALS
       9.21.3 PRODUCTS & SERVICES
       9.21.4 STRATEGY
       9.21.5 DEVELOPMENTS
 
  
LIST OF TABLES 
 
TABLE 1 TYPICAL LABORATORY WORKFLOW STEPS WITH INTEGRATED DIGITAL IMAGING
TABLE 2 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 3 SCANNERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 4 ANALYTICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 5 STORAGE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 6 COMMUNICATION/DELIVERY MODES MARKET REVENUE, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 7 GLOBAL COMMUNICATION MARKET REVENUE, BY DELIVERY MODES, 2010 – 2017 ($MILLION)
TABLE 8 WEB-BASED COMMUNICATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 9 CLOUD-BASED COMMUNICATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 11 GLOBAL HUMAN PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 12 HUMAN PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 14 HOSPITALS/REFERENCE LABS/ACADEMIC MEDICAL CENTERS (AMC) MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 15 EDUCATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 16 GLOBAL ANIMAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 17 ANIMAL PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 19 ACADEMIC AND GOVERNMENT RESEARCH MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 20 CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 21 DIGITAL PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 22 NORTH AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 23 NORTH AMERICA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 24 NORTH AMERICA: REVENUE, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 25 U.S.: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 26 U.S.: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 27 CANADA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 28 CANADA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 29 EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 30 EUROPE: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 31 EUROPE: REVENUE, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 32 U.K.: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 33 U.K.: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 34 GERMANY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 35 GERMANY: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 36 ITALY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 37 ITALY: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 38 FRANCE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 39 FRANCE: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 40 SPAIN: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 41 SPAIN: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 42 DENMARK: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 43 DENMARK: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 44 NORWAY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 45 NORWAY: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 46 SWEDEN: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 47 SWEDEN: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 48 REST OF EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 49 REST OF EUROPE: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 50 ASIA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 51 ASIA : REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 52 ASIA : DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRIES, 2010 – 2017 ($MILLION)
TABLE 53 CHINA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 54 CHINA : REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 55 JAPAN : REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 JAPAN: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 57 INDIA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 58 INDIA : REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 59 REST OF ASIA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 60 REST OF ASIA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 61 ROW: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 62 ROW: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 63 ROW: REVENUE, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 64 LATIN AMERICA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 65 LATIN AMERICA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 66 AFRICA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 67 AFRICA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 68 RUSSIA: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 69 RUSSIA: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 70 MIDDLE EAST: REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 71 MIDDLE EAST: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 72 PACIFIC COUNTRIES : DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 PACIFIC COUNTRIES: REVENUE, BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 74 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 75 AGREEMENTS/PARTNERSHIPS/COLLABORATIONS/JOINT VENTURES, 2009 – 2012
TABLE 76 NEW PRODUCT LAUNCH, 2009 – 2012
TABLE 77 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 78 HAMAMATSU PHOTONICS K.K.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 79 HAMAMATSU PHOTONICS K.K.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)

Digital pathology offers a myriad of benefits to the fields of diagnostic care, medical/clinical research, education, etc. Pathologists, in particular, are finding it increasingly important in their field of work, as the technology provides instant access to premium quality whole slide images for rapid diagnosis, secondary consultation without any geographic barriers, and long-term preservation of digital samples. It is estimated that digital pathology has a great impact on healthcare diagnostic and treatment decisions, as much as 70%, and hence, holds a crucial position in the diagnostic and treatment process. The global market is estimated to be $191.00 million in 2012, and is expected to reach $336.6 million by 2017.

Digital pathology is a new generation of technology for pathological laboratories. It broadly includes management and analysis of pathology information obtained by digitization of glass slides using slide scanners. Adoption of digital pathology is well on the move across the globe. More than 1,000 systems have been installed for use in clinical, education, research, and biopharma applications worldwide.

The market is broadly segmented into two categories based on its products and application. The product category includes scanners, analytics (visualization software, information management systems and image analysis platforms), storage and communication (sharing services, software), while the application category comprises human pathology and animal pathology. Both these markets are dominated by North America in 2012, followed by Europe, Asia, and Rest of the World (RoW).

This market is dominated by Aperio Technologies, Inc. Ventana Medical Systems, Inc. holds the second position of the total market. Other prominent players in the market include Hamamatsu Photonics K.K. (Japan), 3DHistech, Ltd. (Hungary), Leica Microsystems GmbH (Germany), Omnyx, LLC (U.S.), Nikon Instruments, Inc. (U.S.), Philips Healthcare (Germany), Digipath, Inc. (U.S.), Mikroscan Technologies, Inc. (U.S.), DMetrix, Inc. (U.S.), and Claro, Inc. (Japan).

Global Digital Pathology Market, 2012 – 2017

Digital Pathology Market

Source: MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports